| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031148 |
| Receipt No. | R000035577 |
| Scientific Title | Evaluation of the effect of medication adherence using Pletaal Assist System |
| Date of disclosure of the study information | 2018/02/10 |
| Last modified on | 2021/08/09 (Ver. 5) |
| Basic information | ||
| Public title | Evaluation of the effect of medication adherence using Pletaal Assist System | |
| Acronym | Evaluation of the effect of medication adherence using Pletaal Assist System | |
| Scientific Title | Evaluation of the effect of medication adherence using Pletaal Assist System | |
| Scientific Title:Acronym | Evaluation of the effect of medication adherence using Pletaal Assist System | |
| Region |
|
|
| Condition | ||
| Condition | Ischemic stroke | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of the effect of Pletaal assist system on medication adherence. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Compliance rate of medication while before, during, and after using Pletaal Assist System. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Use of medication support system (Pletaal Assist System) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) 20 years old and over
2) History of non-cardioembolic cerebral infarction, and cilostazol is orally administered for more than 3 months |
|||
| Key exclusion criteria | 1) Patients falling under the cilostazol contraindication
2) Patients who can not understand how to use the Pletaal Assist System due to cognitive dysfunction or brain dysfunction 3) Patients who can not recognize blinking of the lamp of the Pletaal Assist System due to visual disturbance 4) Patients who are incapable of self-management of internal medicine due to motor paralysis or ataxia 5) Other conditions which the physician deems inappropriate. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Iwate medical university | ||||||
| Division name | Department of Internal medicine, Division of Neurology and Gerontology | ||||||
| Zip code | 020-8505 | ||||||
| Address | 19-1, Uchimaru, Morioka, Iwate | ||||||
| TEL | 019-651-5111 | ||||||
| koura@iwate-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Iwate medical university | ||||||
| Division name | Department of Internal medicine, Division of Neurology and Gerontology | ||||||
| Zip code | 020-8505 | ||||||
| Address | 19-1, Uchimaru, Morioka, Iwate | ||||||
| TEL | 019-651-5111 | ||||||
| Homepage URL | |||||||
| koura@iwate-med.ac.jp | |||||||
| Sponsor | |
| Institute | Iwate medical university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Iwate medical university |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Iwate Medical University |
| Address | 19-1 Uchimaru, Morioka, Iwate, Japan |
| Tel | 019-651-5111 |
| ikyomu@j.iwate-med.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035577 |